 | • レポートコード：20QY06-01388 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ガバペンチン薬のグローバル市場について種類別（カプセル、タブレット、経口剤）、用途別（成人帯状疱疹後神経痛、部分発作、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ガバペンチン薬市場の概要 ・世界の主要地域別ガバペンチン薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のガバペンチン薬市場規模2015-2026：種類別（カプセル、タブレット、経口剤） ・世界のガバペンチン薬市場規模2015-2026：用途別（成人帯状疱疹後神経痛、部分発作、その他） ・ガバペンチン薬の北米市場規模2015-2020 ・ガバペンチン薬のヨーロッパ市場規模2015-2020 ・ガバペンチン薬の中国市場規模2015-2020 ・ガバペンチン薬の日本市場規模2015-2020 ・ガバペンチン薬の東南アジア市場規模2015-2020 ・ガバペンチン薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、Depomed、Apotex、Teva、Acella Pharmaceuticals、Taro、Sun Pharmaceutical、Glenmark、Amneal Pharmaceuticals、Aurobindo Pharma、Zydus Pharmaceuticals、Hi-Tech Pharmaceuticals、Marksans Pharma、Mylan、InvaGen Pharmaceuticals、Alkem Laboratories、Tris Pharma、ACI HealthCare Limited、Jiangsu Hengrui Medicine、CSPC Ouyi Pharmaceutical、Sciegen Pharmaceuticals、Epic Pharma、Lupin Limited） ・ガバペンチン薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ガバペンチン薬の市場動向・機会・課題 ・調査の結論 |
Gabapentin (sold under the brand name Neurontin, among others) is a medication which is used to treat partial seizures, neuropathic pain, hot flashes, and restless legs syndrome. It is recommended as one of a number of first-line medications for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. About 15% of those given gabapentin for diabetic neuropathy or postherpetic neuralgia have a measurable benefit. Gabapentin is taken by mouth.
Market Analysis and Insights: Global Gabapentin Drug Market
The global Gabapentin Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Gabapentin Drug Scope and Market Size
The global Gabapentin Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gabapentin Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gabapentin Drug market is segmented into
Capsule
Tablet
Oral solution
Segment by Application, the Gabapentin Drug market is segmented into
Postherpetic neuralgia in adults
Partial onset seizures
Others
The Gabapentin Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Gabapentin Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gabapentin Drug Market Share Analysis
Gabapentin Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gabapentin Drug business, the date to enter into the Gabapentin Drug market, Gabapentin Drug product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
Table of Contents
1 Gabapentin Drug Market Overview
1.1 Gabapentin Drug Product Scope
1.2 Gabapentin Drug Segment by Type
1.2.1 Global Gabapentin Drug Sales by Type (2020-2026)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Oral solution
1.3 Gabapentin Drug Segment by Application
1.3.1 Global Gabapentin Drug Sales Comparison by Application (2020-2026)
1.3.2 Postherpetic neuralgia in adults
1.3.3 Partial onset seizures
1.3.4 Others
1.4 Gabapentin Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Gabapentin Drug Sales Growth Rate (2015-2026)
1.4.2 Global Gabapentin Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Gabapentin Drug Price Trends (2015-2026)
2 Gabapentin Drug Estimate and Forecast by Region
2.1 Global Gabapentin Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Gabapentin Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Gabapentin Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Gabapentin Drug Revenue Market Share by Region (2015-2020)
2.3 Global Gabapentin Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Gabapentin Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Gabapentin Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Gabapentin Drug Estimates and Projections (2015-2026)
2.4.2 Europe Gabapentin Drug Estimates and Projections (2015-2026)
2.4.3 China Gabapentin Drug Estimates and Projections (2015-2026)
2.4.4 Japan Gabapentin Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Gabapentin Drug Estimates and Projections (2015-2026)
2.4.6 India Gabapentin Drug Estimates and Projections (2015-2026)
3 Global Gabapentin Drug Competition Landscape by Players
3.1 Global Top Gabapentin Drug Players by Sales (2015-2020)
3.2 Global Top Gabapentin Drug Players by Revenue (2015-2020)
3.3 Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin Drug as of 2019)
3.4 Global Gabapentin Drug Average Price by Company (2015-2020)
3.5 Manufacturers Gabapentin Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Gabapentin Drug Players (Opinion Leaders)
4 Global Gabapentin Drug Market Size by Type
4.1 Global Gabapentin Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Gabapentin Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Gabapentin Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Gabapentin Drug Price by Type (2014-2020)
4.2 Global Gabapentin Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Gabapentin Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Gabapentin Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Gabapentin Drug Price Forecast by Type (2021-2026)
5 Global Gabapentin Drug Market Size by Application
5.1 Global Gabapentin Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Gabapentin Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Gabapentin Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Gabapentin Drug Price by Application (2015-2020)
5.2 Global Gabapentin Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Gabapentin Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Gabapentin Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Gabapentin Drug Price Forecast by Application (2021-2026)
3 North America Gabapentin Drug Market Facts & Figures
3.2 North America Gabapentin Drug Sales Market Share by Company (2015-2020)
3.3 North America Gabapentin Drug Sales Market Share by Type (2015-2020)
3.4 North America Gabapentin Drug Sales Market Share by Application (2015-2020)
4 Europe Gabapentin Drug Market Facts & Figures
4.2 Europe Gabapentin Drug Sales Market Share by Company (2015-2020)
4.3 Europe Gabapentin Drug Sales Market Share by Type (2015-2020)
4.4 Europe Gabapentin Drug Sales Market Share by Application (2015-2020)
5 China Gabapentin Drug Market Facts & Figures
5.2 China Gabapentin Drug Sales Market Share by Company (2015-2020)
5.3 China Gabapentin Drug Sales Market Share by Type (2015-2020)
5.4 China Gabapentin Drug Sales Market Share by Application (2015-2020)
6 Japan Gabapentin Drug Market Facts & Figures
6.2 Japan Gabapentin Drug Sales Market Share by Company (2015-2020)
6.3 Japan Gabapentin Drug Sales Market Share by Type (2015-2020)
6.4 Japan Gabapentin Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Gabapentin Drug Market Facts & Figures
7.2 Southeast Asia Gabapentin Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Gabapentin Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Gabapentin Drug Sales Market Share by Application (2015-2020)
8 India Gabapentin Drug Market Facts & Figures
8.2 India Gabapentin Drug Sales Market Share by Company (2015-2020)
8.3 India Gabapentin Drug Sales Market Share by Type (2015-2020)
8.4 India Gabapentin Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Gabapentin Drug Business
12.1 Pfizer
12.1.1 Pfizer Gabapentin Drug Corporation Information
12.1.2 Pfizer Gabapentin Drug Business Overview and Total Revenue
12.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Gabapentin Drug Products Offered
12.1.5 Pfizer Recent Development
12.2 Depomed
12.2.1 Depomed Gabapentin Drug Corporation Information
12.2.2 Depomed Gabapentin Drug Business Overview and Total Revenue
12.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Depomed Gabapentin Drug Products Offered
12.2.5 Depomed Recent Development
12.3 Apotex
12.3.1 Apotex Gabapentin Drug Corporation Information
12.3.2 Apotex Gabapentin Drug Business Overview and Total Revenue
12.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Apotex Gabapentin Drug Products Offered
12.3.5 Apotex Recent Development
12.4 Teva
12.4.1 Teva Gabapentin Drug Corporation Information
12.4.2 Teva Gabapentin Drug Business Overview and Total Revenue
12.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teva Gabapentin Drug Products Offered
12.4.5 Teva Recent Development
12.5 Acella Pharmaceuticals
12.5.1 Acella Pharmaceuticals Gabapentin Drug Corporation Information
12.5.2 Acella Pharmaceuticals Gabapentin Drug Business Overview and Total Revenue
12.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Acella Pharmaceuticals Gabapentin Drug Products Offered
12.5.5 Acella Pharmaceuticals Recent Development
12.6 Taro
12.6.1 Taro Gabapentin Drug Corporation Information
12.6.2 Taro Gabapentin Drug Business Overview and Total Revenue
12.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Taro Gabapentin Drug Products Offered
12.6.5 Taro Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Gabapentin Drug Corporation Information
12.7.2 Sun Pharmaceutical Gabapentin Drug Business Overview and Total Revenue
12.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sun Pharmaceutical Gabapentin Drug Products Offered
12.7.5 Sun Pharmaceutical Recent Development
12.8 Glenmark
12.8.1 Glenmark Gabapentin Drug Corporation Information
12.8.2 Glenmark Gabapentin Drug Business Overview and Total Revenue
12.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Glenmark Gabapentin Drug Products Offered
12.8.5 Glenmark Recent Development
12.9 Amneal Pharmaceuticals
12.9.1 Amneal Pharmaceuticals Gabapentin Drug Corporation Information
12.9.2 Amneal Pharmaceuticals Gabapentin Drug Business Overview and Total Revenue
12.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Amneal Pharmaceuticals Gabapentin Drug Products Offered
12.9.5 Amneal Pharmaceuticals Recent Development
12.10 Aurobindo Pharma
12.10.1 Aurobindo Pharma Gabapentin Drug Corporation Information
12.10.2 Aurobindo Pharma Gabapentin Drug Business Overview and Total Revenue
12.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Aurobindo Pharma Gabapentin Drug Products Offered
12.10.5 Aurobindo Pharma Recent Development
12.11 Zydus Pharmaceuticals
12.11.1 Zydus Pharmaceuticals Gabapentin Drug Corporation Information
12.11.2 Zydus Pharmaceuticals Gabapentin Drug Business Overview and Total Revenue
12.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Zydus Pharmaceuticals Gabapentin Drug Products Offered
12.11.5 Zydus Pharmaceuticals Recent Development
12.12 Hi-Tech Pharmaceuticals
12.12.1 Hi-Tech Pharmaceuticals Gabapentin Drug Corporation Information
12.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Business Overview and Total Revenue
12.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Products Offered
12.12.5 Hi-Tech Pharmaceuticals Recent Development
12.13 Marksans Pharma
12.13.1 Marksans Pharma Gabapentin Drug Corporation Information
12.13.2 Marksans Pharma Gabapentin Drug Business Overview and Total Revenue
12.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Marksans Pharma Gabapentin Drug Products Offered
12.13.5 Marksans Pharma Recent Development
12.14 Mylan
12.14.1 Mylan Gabapentin Drug Corporation Information
12.14.2 Mylan Gabapentin Drug Business Overview and Total Revenue
12.14.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Mylan Gabapentin Drug Products Offered
12.14.5 Mylan Recent Development
12.15 InvaGen Pharmaceuticals
12.15.1 InvaGen Pharmaceuticals Gabapentin Drug Corporation Information
12.15.2 InvaGen Pharmaceuticals Gabapentin Drug Business Overview and Total Revenue
12.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 InvaGen Pharmaceuticals Gabapentin Drug Products Offered
12.15.5 InvaGen Pharmaceuticals Recent Development
12.16 Alkem Laboratories
12.16.1 Alkem Laboratories Gabapentin Drug Corporation Information
12.16.2 Alkem Laboratories Gabapentin Drug Business Overview and Total Revenue
12.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Alkem Laboratories Gabapentin Drug Products Offered
12.16.5 Alkem Laboratories Recent Development
12.17 Tris Pharma
12.17.1 Tris Pharma Gabapentin Drug Corporation Information
12.17.2 Tris Pharma Gabapentin Drug Business Overview and Total Revenue
12.17.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Tris Pharma Gabapentin Drug Products Offered
12.17.5 Tris Pharma Recent Development
12.18 ACI HealthCare Limited
12.18.1 ACI HealthCare Limited Gabapentin Drug Corporation Information
12.18.2 ACI HealthCare Limited Gabapentin Drug Business Overview and Total Revenue
12.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.18.4 ACI HealthCare Limited Gabapentin Drug Products Offered
12.18.5 ACI HealthCare Limited Recent Development
12.19 Jiangsu Hengrui Medicine
12.19.1 Jiangsu Hengrui Medicine Gabapentin Drug Corporation Information
12.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Business Overview and Total Revenue
12.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Products Offered
12.19.5 Jiangsu Hengrui Medicine Recent Development
12.20 CSPC Ouyi Pharmaceutical
12.20.1 CSPC Ouyi Pharmaceutical Gabapentin Drug Corporation Information
12.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Business Overview and Total Revenue
12.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Products Offered
12.20.5 CSPC Ouyi Pharmaceutical Recent Development
12.21 Sciegen Pharmaceuticals
12.21.1 Sciegen Pharmaceuticals Gabapentin Drug Corporation Information
12.21.2 Sciegen Pharmaceuticals Gabapentin Drug Business Overview and Total Revenue
12.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Sciegen Pharmaceuticals Gabapentin Drug Products Offered
12.21.5 Sciegen Pharmaceuticals Recent Development
12.22 Epic Pharma
12.22.1 Epic Pharma Gabapentin Drug Corporation Information
12.22.2 Epic Pharma Gabapentin Drug Business Overview and Total Revenue
12.22.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Epic Pharma Gabapentin Drug Products Offered
12.22.5 Epic Pharma Recent Development
12.23 Lupin Limited
12.23.1 Lupin Limited Gabapentin Drug Corporation Information
12.23.2 Lupin Limited Gabapentin Drug Business Overview and Total Revenue
12.23.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Lupin Limited Gabapentin Drug Products Offered
12.23.5 Lupin Limited Recent Development
13 Gabapentin Drug Manufacturing Cost Analysis
13.1 Gabapentin Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gabapentin Drug
13.4 Gabapentin Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gabapentin Drug Distributors List
14.3 Gabapentin Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Gabapentin Drug Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Gabapentin Drug Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Gabapentin Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Gabapentin Drug Sales (K MT) by Region (2015-2020)
Table 5. Global Gabapentin Drug Sales Market Share by Region (2015-2020)
Table 6. Global Gabapentin Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Gabapentin Drug Revenue Share by Region (2015-2020)
Table 8. Global Gabapentin Drug Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Gabapentin Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Gabapentin Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Gabapentin Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Gabapentin Drug (K MT) of Key Companies (2015-2020)
Table 13. Global Gabapentin Drug Sales Share by Company (2015-2020)
Table 14. Global Gabapentin Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Gabapentin Drug Revenue Share by Company (2015-2020)
Table 16. Global Gabapentin Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin Drug as of 2019)
Table 17. Global Gabapentin Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Gabapentin Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Gabapentin Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Gabapentin Drug Players
Table 22. Global Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 23. Global Gabapentin Drug Sales Share by Type (2015-2020)
Table 24. Global Gabapentin Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Gabapentin Drug Price (K MT) by Type (2015-2020)
Table 26. Global Gabapentin Drug Sales Share by Type (2021-2026)
Table 27. Global Gabapentin Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Gabapentin Drug Revenue Share by Type (2021-2026)
Table 29. Global Gabapentin Drug Price (K MT) by Type (2021-2026)
Table 30. Global Gabapentin Drug Sales (K MT) by Application (2015-2020)
Table 31. Global Gabapentin Drug Sales Share by Application (2015-2020)
Table 32. Global Gabapentin Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Gabapentin Drug Price (K MT) by Application (2015-2020)
Table 34. Global Gabapentin Drug Sales (K MT) by Application (2021-2026)
Table 35. Global Gabapentin Drug Sales Share by Application (2021-2026)
Table 36. Global Gabapentin Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Gabapentin Drug Revenue Share by Application (2021-2026)
Table 38. Global Gabapentin Drug Price (K MT) by Application (2021-2026)
Table 39. United States Gabapentin Drug Sales (K MT) by Company (2015-2020)
Table 40. United States Gabapentin Drug Sales Market Share by Company (2015-2020)
Table 41. United States Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 42. United States Gabapentin Drug Sales Market Share by Type (2015-2020)
Table 43. United States Gabapentin Drug Sales (K MT) by Application (2015-2020)
Table 44. United States Gabapentin Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Gabapentin Drug Sales (K MT) by Company (2015-2020)
Table 46. Europe Gabapentin Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 48. Europe Gabapentin Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Gabapentin Drug Sales (K MT) by Application (2015-2020)
Table 50. Europe Gabapentin Drug Sales Market Share by Type (2015-2020)
Table 51. China Gabapentin Drug Sales (K MT) by Company (2015-2020)
Table 52. China Gabapentin Drug Sales Market Share by Company (2015-2020)
Table 53. China Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 54. China Gabapentin Drug Sales Market Share by Type (2015-2020)
Table 55. China Gabapentin Drug Sales (K MT) by Application (2015-2020)
Table 56. China Gabapentin Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Gabapentin Drug Sales (K MT) by Company (2015-2020)
Table 58. Japan Gabapentin Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 60. Japan Gabapentin Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Gabapentin Drug Sales (K MT) by Application (2015-2020)
Table 62. Japan Gabapentin Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Gabapentin Drug Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Gabapentin Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Gabapentin Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Gabapentin Drug Sales Market Share by Application (2015-2020)
Table 69. India Gabapentin Drug Sales (K MT) by Company (2015-2020)
Table 70. India Gabapentin Drug Sales Market Share by Company (2015-2020)
Table 71. India Gabapentin Drug Sales (K MT) by Type (2015-2020)
Table 72. India Gabapentin Drug Sales Market Share by Type (2015-2020)
Table 73. India Gabapentin Drug Sales (K MT) by Application (2015-2020)
Table 74. India Gabapentin Drug Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Gabapentin Drug Product
Table 79. Pfizer Recent Development
Table 80. Depomed Corporation Information
Table 81. Depomed Description and Business Overview
Table 82. Depomed Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Depomed Gabapentin Drug Product
Table 84. Depomed Recent Development
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Apotex Gabapentin Drug Product
Table 89. Apotex Recent Development
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Teva Gabapentin Drug Product
Table 94. Teva Recent Development
Table 95. Acella Pharmaceuticals Corporation Information
Table 96. Acella Pharmaceuticals Description and Business Overview
Table 97. Acella Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Acella Pharmaceuticals Gabapentin Drug Product
Table 99. Acella Pharmaceuticals Recent Development
Table 100. Taro Corporation Information
Table 101. Taro Description and Business Overview
Table 102. Taro Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Taro Gabapentin Drug Product
Table 104. Taro Recent Development
Table 105. Sun Pharmaceutical Corporation Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sun Pharmaceutical Gabapentin Drug Product
Table 109. Sun Pharmaceutical Recent Development
Table 110. Glenmark Corporation Information
Table 111. Glenmark Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Glenmark Description and Business Overview
Table 113. Glenmark Gabapentin Drug Product
Table 114. Glenmark Recent Development
Table 115. Amneal Pharmaceuticals Corporation Information
Table 116. Amneal Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Amneal Pharmaceuticals Description and Business Overview
Table 118. Amneal Pharmaceuticals Gabapentin Drug Product
Table 119. Amneal Pharmaceuticals Recent Development
Table 120. Aurobindo Pharma Corporation Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Aurobindo Pharma Gabapentin Drug Product
Table 124. Aurobindo Pharma Recent Development
Table 125. Zydus Pharmaceuticals Corporation Information
Table 126. Zydus Pharmaceuticals Description and Business Overview
Table 127. Zydus Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Zydus Pharmaceuticals Gabapentin Drug Product
Table 129. Zydus Pharmaceuticals Recent Development
Table 130. Hi-Tech Pharmaceuticals Corporation Information
Table 131. Hi-Tech Pharmaceuticals Description and Business Overview
Table 132. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Hi-Tech Pharmaceuticals Gabapentin Drug Product
Table 134. Hi-Tech Pharmaceuticals Recent Development
Table 135. Marksans Pharma Corporation Information
Table 136. Marksans Pharma Description and Business Overview
Table 137. Marksans Pharma Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Marksans Pharma Gabapentin Drug Product
Table 139. Marksans Pharma Recent Development
Table 140. Mylan Corporation Information
Table 141. Mylan Description and Business Overview
Table 142. Mylan Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Mylan Gabapentin Drug Product
Table 144. Mylan Recent Development
Table 145. InvaGen Pharmaceuticals Corporation Information
Table 146. InvaGen Pharmaceuticals Description and Business Overview
Table 147. InvaGen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. InvaGen Pharmaceuticals Gabapentin Drug Product
Table 149. InvaGen Pharmaceuticals Recent Development
Table 150. Alkem Laboratories Corporation Information
Table 151. Alkem Laboratories Description and Business Overview
Table 152. Alkem Laboratories Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Alkem Laboratories Gabapentin Drug Product
Table 154. Alkem Laboratories Recent Development
Table 155. Tris Pharma Corporation Information
Table 156. Tris Pharma Description and Business Overview
Table 157. Tris Pharma Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Tris Pharma Gabapentin Drug Product
Table 159. Tris Pharma Recent Development
Table 160. ACI HealthCare Limited Corporation Information
Table 161. ACI HealthCare Limited Description and Business Overview
Table 162. ACI HealthCare Limited Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. ACI HealthCare Limited Gabapentin Drug Product
Table 164. ACI HealthCare Limited Recent Development
Table 165. Jiangsu Hengrui Medicine Corporation Information
Table 166. Jiangsu Hengrui Medicine Description and Business Overview
Table 167. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Jiangsu Hengrui Medicine Gabapentin Drug Product
Table 169. Jiangsu Hengrui Medicine Recent Development
Table 170. CSPC Ouyi Pharmaceutical Corporation Information
Table 171. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 172. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. CSPC Ouyi Pharmaceutical Gabapentin Drug Product
Table 174. CSPC Ouyi Pharmaceutical Recent Development
Table 175. Sciegen Pharmaceuticals Corporation Information
Table 176. Sciegen Pharmaceuticals Description and Business Overview
Table 177. Sciegen Pharmaceuticals Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Sciegen Pharmaceuticals Gabapentin Drug Product
Table 179. Sciegen Pharmaceuticals Recent Development
Table 180. Epic Pharma Corporation Information
Table 181. Epic Pharma Description and Business Overview
Table 182. Epic Pharma Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Epic Pharma Gabapentin Drug Product
Table 184. Epic Pharma Recent Development
Table 185. Lupin Limited Corporation Information
Table 186. Lupin Limited Description and Business Overview
Table 187. Lupin Limited Gabapentin Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Lupin Limited Gabapentin Drug Product
Table 189. Lupin Limited Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Gabapentin Drug Distributors List
Table 193. Gabapentin Drug Customers List
Table 194. Market Key Trends
Table 195. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 196. Key Challenges
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Drug Product Picture
Figure 2. Global Gabapentin Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gabapentin Drug Market Share by Application in 2020 & 2026
Figure 6. Postherpetic neuralgia in adults Examples
Figure 7. Partial onset seizures Examples
Figure 8. Others Examples
Figure 9. Global Gabapentin Drug Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Gabapentin Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Gabapentin Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Gabapentin Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Gabapentin Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Gabapentin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Gabapentin Drug Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Gabapentin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Gabapentin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Gabapentin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Gabapentin Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Gabapentin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Gabapentin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Gabapentin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Gabapentin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Gabapentin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Gabapentin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Gabapentin Drug Players Market Share by Revenue in Gabapentin Drug 2015 & 2019
Figure 27. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Gabapentin Drug Revenue Share by Type (2015-2020)
Figure 29. Global Gabapentin Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Gabapentin Drug Revenue Share by Application (2015-2020)
Figure 31. Global Gabapentin Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Gabapentin Drug Sales Market Share by Type in 2019
Figure 33. United States Gabapentin Drug Sales Market Share by Type in 2019
Figure 34. Europe Gabapentin Drug Sales Market Share by Company in 2019
Figure 35. Europe Gabapentin Drug Sales Market Share by Type in 2019
Figure 36. Europe Gabapentin Drug Sales Market Share by Application in 2019
Figure 37. China Gabapentin Drug Sales Market Share by Company in 2019
Figure 38. China Gabapentin Drug Sales Market Share by Type in 2019
Figure 39. China Gabapentin Drug Sales Market Share by Application in 2019
Figure 40. Japan Gabapentin Drug Sales Market Share by Company in 2019
Figure 41. Japan Gabapentin Drug Sales Market Share by Type in 2019
Figure 42. Japan Gabapentin Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Gabapentin Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Gabapentin Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Gabapentin Drug Sales Market Share by Application in 2019
Figure 46. India Gabapentin Drug Sales Market Share by Company in 2019
Figure 47. India Gabapentin Drug Sales Market Share by Type in 2019
Figure 48. India Gabapentin Drug Sales Market Share by Application in 2019
Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Depomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Acella Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Taro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Hi-Tech Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Marksans Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. InvaGen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Alkem Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Tris Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. ACI HealthCare Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Jiangsu Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. CSPC Ouyi Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Sciegen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Epic Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Lupin Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Key Raw Materials Price Trend
Figure 73. Manufacturing Cost Structure of Gabapentin Drug
Figure 74. Manufacturing Process Analysis of Gabapentin Drug
Figure 75. Gabapentin Drug Industrial Chain Analysis
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Porter's Five Forces Analysis
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
経口潰瘍薬の世界市場レポート2020 Market Analysis and Insights: Global Oral Ulcer Drug Market The global Oral Ulcer Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Oral Ulcer Drug Scope and Market Size The global Oral Ulcer Drug mark…- 象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…
- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…
- 植物薬の世界市場レポート2020 Market Analysis and Insights: Global Botanical Drug Market The global Botanical Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Botanical Drug Scope and Market Size The global Botanical Drug market i…
- 経口ドラッグデリバリーの世界市場レポート2020 Market Analysis and Insights: Global Oral Drug Delivery Market The global Oral Drug Delivery market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Oral Drug Delivery Scope and Market Size The global Oral Drug D…